≡

Multiplex Assay Kit for Dopamine Receptor D2 (DRD2) ,etc. by FLIA (Flow Luminescence Immunoassay)

DR-D2; D2DR; D2R

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Dopamine Receptor D2 (DRD2) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Dopamine Receptor D2 (DRD2) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Dopamine Receptor D2 (DRD2) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Dopamine Receptor D2 (DRD2) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 81-94 86
EDTA plasma(n=5) 80-91 83
heparin plasma(n=5) 88-96 93
sodium citrate plasma(n=5) 81-104 91

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Dopamine Receptor D2 (DRD2) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Dopamine Receptor D2 (DRD2) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Dopamine Receptor D2 (DRD2) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 91-101% 95-105% 95-102% 96-104%
EDTA plasma(n=5) 91-99% 88-97% 98-105% 95-105%
heparin plasma(n=5) 84-96% 82-90% 86-103% 79-89%
sodium citrate plasma(n=5) 80-101% 93-103% 79-95% 92-99%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:DRD2) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Front Behav Neurosci Distinct patterns of outcome valuation and amygdala-prefrontal cortex synaptic remodeling in adolescence and adulthood PubMed: 25999830
Behavioural Brain Research Sex differences, learning flexibility, and striatal dopamine D1 and D2 following adolescent drug exposure in rats Pubmed:27091300
South African Journal of Botany Evaluation of the effect of herbal extracts and their bioactive compounds against motion sickness by regulating neurotransmitter levels in vitro and in vivo
UCLA Electronic Theses and Dissertations Benefit, Burdens and Brain Correlates of Heightened Reward Sensitivity in Adolescence
The GLP-1/GIP dual receptor agonist DA5-CH is superior to Exendin-4 in protecting neurons in the 6-OHDA rat Parkinson Model
ВЛИЯНИЕ ХРОНИЧЕСКОГО ВВЕДЕНИЯ НЕЙРОЛЕПТИКОВ НА УРОВНИ НЕЙРОСПЕЦИФИЧЕСКИХ АУТОАНТИТЕЛ В КРОВИ У КРЫС
JOURNAL OF FOOD BIOCHEMISTRY Menthol, a bioactive constituent of Mentha, attenuates motion sickness in mice model: Involvement of dopaminergic system 34245039
Catalog No. Related products for research use of Mus musculus (Mouse) Organism species Applications (RESEARCH USE ONLY!)
RPA673Mu01 Recombinant Dopamine Receptor D2 (DRD2) Positive Control; Immunogen; SDS-PAGE; WB.
PAA673Mu01 Polyclonal Antibody to Dopamine Receptor D2 (DRD2) WB; IHC; ICC; IP.
SEA673Mu ELISA Kit for Dopamine Receptor D2 (DRD2) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA673Mu Multiplex Assay Kit for Dopamine Receptor D2 (DRD2) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.